| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/24/2002 | WO2002006225A1 Preventives or remedies for atopic dermatitis |
| 01/24/2002 | WO2002006223A1 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications |
| 01/24/2002 | WO2002006222A1 Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme |
| 01/24/2002 | WO2002005848A2 Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders |
| 01/24/2002 | WO2002005847A1 Kubouchi's method of intramuscularly injecting mixture of drug with patient's blood and kubouchi's substances produced thereby |
| 01/24/2002 | WO2002005842A2 Preventing airway mucus production by administration of egf-r antagonists |
| 01/24/2002 | WO2002005840A1 Medicinal compositions for promoting fixation of transplanted cells |
| 01/24/2002 | WO2002005834A2 Novel uses for thyroid hormones or thyroid hormone-like agonist compounds for treating dermis conditions |
| 01/24/2002 | WO2002005832A1 Process for preparing composition comprising medicinal herb extract for preventing and curing arthritis and composition thereof |
| 01/24/2002 | WO2002005828A1 Compositions and methods for the treatment of skin damage |
| 01/24/2002 | WO2002005822A2 Compositions containing therapeutically active components having enhanced solubility |
| 01/24/2002 | WO2002005818A2 Novel method of use of multidrug resistance modulators |
| 01/24/2002 | WO2002005814A1 Use of il-8 receptor antagonists in the treatment of virus infections |
| 01/24/2002 | WO2002005812A1 Medicaments for chemotherapeutic treatment of disease |
| 01/24/2002 | WO2002005811A1 Stem cell reinforcing material |
| 01/24/2002 | WO2002005801A2 Compositions containing diacyltartaric salts of (e)-metanicotine |
| 01/24/2002 | WO2002005798A2 Pharmaceutical compositions for treating neurological disorders |
| 01/24/2002 | WO2002005797A2 Use of dopamine d2/d3 receptor agonists to treat fibromyalgia |
| 01/24/2002 | WO2002005796A2 Use of a spla2 inhibitor for the treatment of sepsis |
| 01/24/2002 | WO2002005794A2 Use of fluorescein derivatives for the treatment of diseases responsive to the activation of the cystic fibrosis transmembrane conductance regulator chloride channel |
| 01/24/2002 | WO2002005792A2 Use of matrix metalloprotease inhibitors for the treatment of cancer |
| 01/24/2002 | WO2002005791A2 Antitumor combination comprising an aromatase inhibitor and an egfr antagonist or inhibitor |
| 01/24/2002 | WO2002005786A1 Pharmaceutical composition improved in peroral absorbability |
| 01/24/2002 | WO2002005784A1 A medicinal aerosol formulation |
| 01/24/2002 | WO2002005749A2 Crf2 ligands in combination therapy |
| 01/24/2002 | WO2001078761A3 Mixture of defibrotide and g-csf ant its use for activating haematopoietic progenitors |
| 01/24/2002 | WO2001066132A3 Hiv immune adjuvant therapy |
| 01/24/2002 | WO2001062239A3 Novel compositions and uses of dictyostatin compounds |
| 01/24/2002 | WO2001060814A3 Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 01/24/2002 | WO2001053268B1 Indazole compounds, pharmaceutical compositions, and their use for mediating or inhibiting cell proliferation |
| 01/24/2002 | WO2001052892A3 Jak/stat pathway inhibitors and the uses thereof |
| 01/24/2002 | WO2001052878A3 The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotective therapy |
| 01/24/2002 | WO2001051071A3 Transepithelial delivery of glp-1 derivatives |
| 01/24/2002 | WO2001046258A3 Transporters and ion channels |
| 01/24/2002 | WO2001042465A3 Chordin-like molecules and uses thereof |
| 01/24/2002 | WO2001038305A3 Novel il-8 receptor antagonists |
| 01/24/2002 | WO2001032655A3 Quinoline and naphthyridine carboxylic acid antibacterials |
| 01/24/2002 | WO2001032627A8 Process of making substituted pyrazoles |
| 01/24/2002 | WO2001032154A3 Use of treosulfan for patient conditioning before bone marrow or blood stem cell transplantation |
| 01/24/2002 | WO2001029037A3 Condensed naphthyridines as hiv reverse transcriptase inhibitors |
| 01/24/2002 | WO2001029000A3 Bicyclic and tricyclic amines as modulators of chemokine receptor activity |
| 01/24/2002 | WO2001027107A3 Heterocyclic sodium/proton exchange inhibitors and method |
| 01/24/2002 | WO2001025436A3 Endozepine-like polypeptides and polynucleotides encoding same |
| 01/24/2002 | WO2001025397A3 Compositions and methods for tumor-targeted delivery of effector molecules |
| 01/24/2002 | WO2001023387A3 CERTAIN ALKYLENE DIAMINE-SUBSTITUTED PYRAZOLO[1,5,-a]-1,5-PYRIMIDINES AND PYRAZOLO[1,5-a]-1,3,5-TRIAZINES |
| 01/24/2002 | WO2001023385A3 Novel tropane analogs |
| 01/24/2002 | WO2001023357A3 Fused cycloheptane and fused azacycloheptane compounds and their use as integrin receptor antagonists |
| 01/24/2002 | WO2001019855A3 Pharmaceutical compositions and methods of using secreted frizzled related protein |
| 01/24/2002 | WO2001017564A3 Enzyme inhibitors |
| 01/24/2002 | WO2001016290A3 Dna encoding the human serine protease eos |
| 01/24/2002 | WO2001014405A3 Methods of obtaining 2-methoxyestradiol of high purity |
| 01/24/2002 | WO2001008708A3 Enhanced delivery via serpin enzyme complex receptor ligands |
| 01/24/2002 | WO2001000655A3 Therapeutic peptides derived from subsequences of bpi |
| 01/24/2002 | US20020010343 Compounds having IgE affecting properties |
| 01/24/2002 | US20020010338 Phenyl-keto-imidazolidine thioamide derivatives |
| 01/24/2002 | US20020010335 Process and intermediates for growth hormone secretagogues |
| 01/24/2002 | US20020010318 Enzyme inhibitor; for use in treatment of lung defects, asthma, bronchitis, emphysema and respiratory system disorders |
| 01/24/2002 | US20020010316 Thiazole derivatives |
| 01/24/2002 | US20020010315 Treatment or amelioration of symptoms of adult respiratory distress syndrome, septic shock, and multiple organ failure. |
| 01/24/2002 | US20020010213 Inhibiting membrane transport mediated by the multidrug resistance associated protein MRP in a patient by administering a compound having an amphiphilic anion and a molecular weight of from 300 to 950 daltons. |
| 01/24/2002 | US20020010206 Treating cyclooxygenase-2 mediated disorders. |
| 01/24/2002 | US20020010203 Methods of modulating c-kit tyrosine protein kinase function with indolinone compounds |
| 01/24/2002 | US20020010196 Antiulcer agents, treatment of gastroesophageal reflux and other conditions related to gastric hypersecretion such as Zollinger-Ellison syndrome |
| 01/24/2002 | US20020010195 Mitochondria protecting agents for treating mitochondria associated diseases |
| 01/24/2002 | US20020010189 For treatment of sexual disorders, male erectile dysfunction |
| 01/24/2002 | US20020010185 Anticarcinogenic agents |
| 01/24/2002 | US20020010183 Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors |
| 01/24/2002 | US20020010181 Angiogenesis inhibitors as antitumor agents |
| 01/24/2002 | US20020010173 Reacting an amide derivative with a piperidine containing guanidine group to produce the product |
| 01/24/2002 | US20020010171 New compounds, their preparation and use |
| 01/24/2002 | US20020010170 Pyrimido(1,6-b)pyridazine derivatives used as p38 inhibitors a mammalian protein kinase is involved in cell proliferation, cell death and response to extracellular stimuli |
| 01/24/2002 | US20020010158 Derivatives of 5-pyridylalkylphosphonates and 5-pyridylalkylmalonates useful drugs for treatment of cardiovascular related diseases and diabetes mellitus related diseases |
| 01/24/2002 | US20020010151 Immuno-active agent, method of its use, and method of immunity activation |
| 01/24/2002 | US20020010146 Nitrosated and nitrosylated taxanes, compositions and methods of use |
| 01/24/2002 | US20020010125 Chemokinesis interferes with immune and inflammatory responses by increasing cell movements and altering cell migration patterns; interfere with spread of malignant cells through the body, and reduce inflammatory responses |
| 01/24/2002 | US20020009800 Genetically engineeered sequences for use in gene therapy of central nervous system |
| 01/24/2002 | US20020009773 Nucleotide sequences coding protein associated with apoptosis; for use in treatment of defects of apoptosis and inflammation |
| 01/24/2002 | US20020009726 CD40 associated proteins |
| 01/24/2002 | US20020009494 Spray drying |
| 01/24/2002 | US20020009478 Aqueous liquid containing colloidal particles |
| 01/24/2002 | US20020009455 Prostate glands; diagnosis, therapy |
| 01/24/2002 | CA2429008A1 Lipid-rich plaque regressing agents |
| 01/24/2002 | CA2419626A1 Imidazo¬1,2-a|pyrazines for the treatment of neurological disorders |
| 01/24/2002 | CA2418288A1 Dihydroxypyrimidine carboxylic acids as viral polymerase inhibitors |
| 01/24/2002 | CA2418162A1 Use of il-8 receptor antagonists in the treatment of virus infections |
| 01/24/2002 | CA2418146A1 Use of matrix metalloprotease inhibitors for the treatment of cancer |
| 01/24/2002 | CA2416986A1 Crf2 ligands in combination therapy |
| 01/24/2002 | CA2416452A1 Novel proteins and nucleic acids encoding same |
| 01/24/2002 | CA2416248A1 5-substituted 2-aryl-4-pyrimidinones |
| 01/24/2002 | CA2416245A1 Cyclic amine phenyl beta-3 adrenergic receptor agonists |
| 01/24/2002 | CA2416153A1 Mutant rad51 paralog genes and use thereof in anticancer therapy |
| 01/24/2002 | CA2416015A1 Matrix metalloproteinase inhibitors |
| 01/24/2002 | CA2415965A1 Oxazolidinone derivatives as antimicrobials |
| 01/24/2002 | CA2415961A1 Production method of 1-substituted-1,2,3-triazole derivatives |
| 01/24/2002 | CA2415932A1 Cyclic oxyguanidine pyrazinones as protease inhibitors |
| 01/24/2002 | CA2415906A1 Compositions containing diacyltartaric salts of (e)-metanicotine |
| 01/24/2002 | CA2415901A1 Pharmaceutical compositions and methods for use |
| 01/24/2002 | CA2415896A1 Use of fluorescein derivatives for the treatment of diseases responsive to the activation of the cystic fibrosis transmembrane conductance regulator chloride channel |
| 01/24/2002 | CA2415701A1 Compositions and methods for the treatment of skin damage |
| 01/24/2002 | CA2415690A1 Tetraspan protein and uses thereof |